Biogen (United States)

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Biogen (United States), United States, covering academic research published from 2000 to 2022. Read More.

Open Access Percentage

55%

Total
Publications

5.5K

Total Open
Publications

Total
Citations

257K

Open Access
Percentage

55%

Total
Publications

5.5K

Total Open
Publications

Total
Citations

257K

Wikipedia

Website

download

Breakdown

Publisher Open

18%

Both

26%

Other Platform Open

11%

Closed

45%

Percentage of Open Access over time

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

Open

Closed

Publisher Open

OA Journal 27%

648

Hybrid 39%

924

No Guarantees 34%

828

Other Platform Open

Domain 82%

1.6K

Institution 28%

564

Other Internet 12%

242

Preprint 10%

200

Public 9%

176

Other Platform Locations

Name	Platform Type	Publications
PubMed Central	Domain	1.6K
Europe PMC	Domain	1.2K
DOI	Other Internet	142
Semantic Scholar	Public	134
bioRxiv	Preprint	107
University College London - UCL Discovery	Institution	99
Figshare	Public	69
University of Cambridge - Apollo	Institution	46
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System	Institution	42
Research Square	Preprint	41

1 / 20

Data updated 15 November 2023